An effective chemotherapy-free regimen of ponatinib plus venetoclax for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia.
Nicholas J ShortMarina Y KonoplevaTapan Mahendra KadiaPartow KebriaeiNaval G DaverXuelin HuangLucia MasarovaRobin CookNitin JainElias J JabbourHagop M KantarjianFarhad RavandiPublished in: American journal of hematology (2021)